伏列素 (LY3540378) 增加脏血流量:一个随机的第一阶段试验
Lai San Tham1, Hiddo J L Heerspink2, Xiaojun Wang3
1Global Pharmacokinetics, Pharmacodynamics and Pharmacometrics, Lilly Centre for Clinical Pharmacology Pte Ltd, Singapore, Singapore.
概括
一种新型治疗药物Volenrelaxin在第一阶段试验中显著改善了 perfusion. 这种药物安全且耐受性良好,支持其用于心脏和脏疾病的发展.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
背景情况:
- 伏列素是一种修饰的人类放松剂,用于增强脏和心脏功能.
- 这项研究评估了volanrelaxin的安全性,药理动力学和药理动力学.
研究的目的:
- 评估volanrelaxin的安全性和耐受性.
- 为了确定volanrelaxin的药理动力学和药理动力学概况.
- 评估伏兰素对功能和血液动力学的影响.
主要方法:
- 第1期,随机,双盲,安慰剂对照研究.
- 单次上升剂量 (SAD) 和多次上升剂量 (MAD) 方案.
- 测量了有效的脏血流量 (ERPF) 和膜过率 (mGFR).
主要成果:
- 伏列素的半衰期延长,ERPF改善了50% (急性) 和44% (慢性).
- 脏动脉阻力下降;血压和脉率呈现剂量依赖的变化.
- 副作用是轻微的,没有增加静止性低血压的风险.
结论:
- 伏列素是安全的,耐受性很好,适合每周一次的皮下注射.
- 持续改善 perfusion 支持其在慢性病和心力衰竭方面的潜力.
- 根据这些积极的发现,进一步的临床开发是有必要的.
相关概念视频
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
211
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
211
Antihypertensive Drugs: Vasodilators
505
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
505
Factors Affecting Renal Clearance: Renal Impairment
86
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
86
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
165
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
165
Antihypertensive Drugs: Direct Renin Inhibitors
597
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
597
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618


